Dividend investing is an excellent strategy for (at least) two reasons. Here are two companies that can pull it off: Amgen ...

Four of the 30 stocks that make up the Dow Jones Industrial Average represent the healthcare sector. Within that group, ...

Are we truly on the brink of a cure for obesity? Or could neglecting the root causes risk worsening the very problems we seek ...

Quantbot Technologies LP boosted its holdings in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 219.5% during the fourth ...

Amgen (NASDAQ:AMGN – Get Free Report) was upgraded by research analysts at StockNews.com from a “buy” rating to a “strong-buy” rating in a research note issued on Saturday. A number of other research ...

Amgen had argued the board is unconstitutional because its actions conflict with federal law and would regulate business ...

The FDA has approved two new denosumab biosimilars that are interchangeable with the reference medications Prolia and Xgeva, ...

Werner Cautreels, PhD, to retire as CEO, while continuing as a Board MemberIain D. Dukes, D Phil, Executive Board Chairman, to become Interim ...

With President Donald Trump expected to levy tariffs on pharmaceuticals manufactured outside the United States, industry ...

BioNTech has shown why it made small cell lung cancer (SCLC) a priority for its PD-L1xVEGF-A bispecific. | BioNTech has shown ...

Piper Sandler analyst David Amsellem reiterated a Buy rating on Corcept Therapeutics (CORT – Research Report) today and set a price target of ...